Peacock Stuart J, Regier Dean A, Raymakers Adam J N, Chan Kelvin K W
Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, British Columbia, Canada.
Cancer Control Research, BC Cancer, Vancouver, British Columbia, Canada.
Healthc Manage Forum. 2019 Nov;32(6):293-298. doi: 10.1177/0840470419870831. Epub 2019 Sep 4.
Expenditure on cancer therapies is rising rapidly in many countries, particularly for cancer drugs. In recent years, this has stimulated a global debate among the public, patients, clinicians, decision-makers, and the pharmaceutical industry on value, affordability, and sustainability propositions relating to cancer therapies. In this article, we discuss some recent developments in evidence-based approaches to priority setting and resource allocation in Canadian cancer systems. These developments include new methods for deliberative public engagement, generating and using real-world evidence, multi-criteria decision analysis, and handling uncertainty with evidence for gene therapies.
在许多国家,癌症治疗费用正在迅速上升,尤其是癌症药物方面。近年来,这引发了公众、患者、临床医生、决策者和制药行业之间关于癌症治疗的价值、可负担性和可持续性主张的全球辩论。在本文中,我们讨论了加拿大癌症系统中基于证据的优先事项设定和资源分配方法的一些最新进展。这些进展包括审议性公众参与的新方法、生成和使用真实世界证据、多标准决策分析以及利用基因治疗证据处理不确定性。